18 April 2016 | News | By BioSpectrum Bureau
Lambda appointed new president
Singapore: Lambda Therapeutic Research announces the joining of Dr Tausif Monif as President - Global Operations.
Lambda is a leading Global CRO in the Clinical research domain headquartered in Ahmedabad (India), its global footprint encompasses strategically located offices in Mumbai (India), Poland (Europe), London (UK), USA and Canada (North America) offering End to End Clinical Research and total drug development solutions to Pharmaceutical companies worldwide.
Lambda is accreditated by various worldwide Regulatory Authorities like ANVISA-Brazil, EMA, UK-MHRA, POLISH, ANSM (France), TGA-Australia, AGES (Austria), OGYI (Hungary), Turkey MOH,TPS-Canada, USFDA and WHO.
Dr Tausif brings with him a rich experience of more than 24 years in the Clinical Research Industry. His joining Lambda will support the company's vision of expanding their Global footprints.
He has numerous publications and academic accreditations to his credit and has successfully faced multiple Regulatory Audits across the world in his illustrious career.
"I am pretty confident that his rich experience will help in driving Lambda's growth globally," says Mrs Bindi Chudgar, MD of Lambda Therapeutic Research.